Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (“SCT”) announced that Dr. Allen Davidoff, VP Product Development, will be presenting today at the 2nd Annual Stem Cell Summit which is being held at the Wyndham San Diego at Emerald Plaza in San Diego, California on February 12 and 13, 2007. Dr. Davidoff’s presentation will discuss how SCT’s lead program, NTxTM- 265, represents a new conceptual approach in the struggle to develop effective stroke treatments.
